CD8A and neoplasm: In a mammary cancer mouse model with the immune-excluded phenotype, combined treatment with anti-PD-L1 and anti-TGFβ antibodies significantly reduced tumor burden and increased tumor-infiltrating T cells, especially CD8+ T effector cells 73.